U.S. markets open in 7 hours 9 minutes
  • S&P Futures

    3,660.75
    +6.50 (+0.18%)
     
  • Dow Futures

    29,292.00
    +7.00 (+0.02%)
     
  • Nasdaq Futures

    11,257.25
    +29.00 (+0.26%)
     
  • Russell 2000 Futures

    1,685.00
    +2.90 (+0.17%)
     
  • Crude Oil

    81.38
    +0.15 (+0.18%)
     
  • Gold

    1,676.30
    +7.70 (+0.46%)
     
  • Silver

    18.94
    +0.23 (+1.25%)
     
  • EUR/USD

    0.9817
    -0.0002 (-0.02%)
     
  • 10-Yr Bond

    3.7470
    0.0000 (0.00%)
     
  • Vix

    31.84
    +1.66 (+5.50%)
     
  • GBP/USD

    1.1121
    -0.0002 (-0.02%)
     
  • USD/JPY

    144.4720
    +0.0290 (+0.02%)
     
  • BTC-USD

    19,469.36
    +111.69 (+0.58%)
     
  • CMC Crypto 200

    444.82
    -1.16 (-0.26%)
     
  • FTSE 100

    6,881.59
    -123.80 (-1.77%)
     
  • Nikkei 225

    25,937.21
    -484.84 (-1.83%)
     

MorphoSys AG (MOR) Q2 2022 Earnings Call Transcript

·36 min read
MorphoSys AG (MOR) Q2 2022 Earnings Call Transcript

At this time, I would like to turn the conference over to Julia Neugebauer. My name is Julia Neugebauer, head of investor relations at MorphoSys, and it is my pleasure to welcome you to our half year 2022 financial results conference call. With me on the call today are Jean-Paul Kress, chief executive officer; Sung Lee, chief financial officer; Malte Peters, chief research and development officer; and Joe Horvat, U.S. general manager.